Safety and efficacy of targeted alpha therapy with 213Bi-DOTA-substance P in recurrent glioblastoma.
Quick Facts
What This Study Found
Key Numbers
How They Did This
Why This Research Matters
What This Study Doesn't Tell Us
Trust & Context
- Original Title:
- Safety and efficacy of targeted alpha therapy with 213Bi-DOTA-substance P in recurrent glioblastoma.
- Published In:
- European journal of nuclear medicine and molecular imaging, 46(3), 614-622 (2019)
- Authors:
- Królicki, Leszek, Bruchertseifer, Frank, Kunikowska, Jolanta, Koziara, Henryk, Królicki, Bartosz, Jakuciński, Maciej, Pawlak, Dariusz, Apostolidis, Christos, Mirzadeh, Saed, Rola, Rafał, Merlo, Adrian, Morgenstern, Alfred
- Database ID:
- RPEP-04296
Evidence Hierarchy
Read More on RethinkPeptides
Related articles coming soon.
Cite This Study
https://rethinkpeptides.com/research/RPEP-04296APA
Królicki, Leszek; Bruchertseifer, Frank; Kunikowska, Jolanta; Koziara, Henryk; Królicki, Bartosz; Jakuciński, Maciej; Pawlak, Dariusz; Apostolidis, Christos; Mirzadeh, Saed; Rola, Rafał; Merlo, Adrian; Morgenstern, Alfred. (2019). Safety and efficacy of targeted alpha therapy with 213Bi-DOTA-substance P in recurrent glioblastoma.. European journal of nuclear medicine and molecular imaging, 46(3), 614-622. https://doi.org/10.1007/s00259-018-4225-7
MLA
Królicki, Leszek, et al. "Safety and efficacy of targeted alpha therapy with 213Bi-DOTA-substance P in recurrent glioblastoma.." European journal of nuclear medicine and molecular imaging, 2019. https://doi.org/10.1007/s00259-018-4225-7
RethinkPeptides
RethinkPeptides Research Database. "Safety and efficacy of targeted alpha therapy with 213Bi-DOT..." RPEP-04296. Retrieved from https://rethinkpeptides.com/research/krolicki-2019-safety-and-efficacy-of
Access the Original Study
Study data sourced from PubMed, a service of the U.S. National Library of Medicine, National Institutes of Health.
This study breakdown was produced by the RethinkPeptides research team. We analyze and report published research findings without making health recommendations. All interpretations are based solely on the published abstract and study data.